Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies.
ÂgeExpression génétique
#3
Le tabagisme affecte-t-il Wnt-5a ?
Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer.
TabagismeRisque de cancer
#4
Y a-t-il un lien entre l'alimentation et Wnt-5a ?
Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a.
AlimentationGraisses alimentaires
#5
Le stress chronique impacte-t-il Wnt-5a ?
Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies.
Stress chroniqueRégulation hormonale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine Wnt-5a : Questions médicales les plus fréquentes",
"headline": "Protéine Wnt-5a : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine Wnt-5a : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-28",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de type Wingless",
"url": "https://questionsmedicales.fr/mesh/D051153",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de type Wingless",
"code": {
"@type": "MedicalCode",
"code": "D051153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.984"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a",
"alternateName": "Wnt-5a Protein",
"code": {
"@type": "MedicalCode",
"code": "D000071818",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Soon B Hwang",
"url": "https://questionsmedicales.fr/author/Soon%20B%20Hwang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea sbhwang@jbnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Rui Zhou",
"url": "https://questionsmedicales.fr/author/Rui%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China."
}
},
{
"@type": "Person",
"name": "Xiang-Dong Li",
"url": "https://questionsmedicales.fr/author/Xiang-Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn."
}
},
{
"@type": "Person",
"name": "Richa Mishra",
"url": "https://questionsmedicales.fr/author/Richa%20Mishra",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
},
{
"@type": "Person",
"name": "Soumendra Rana",
"url": "https://questionsmedicales.fr/author/Soumendra%20Rana",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/37719730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1207284"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tuberculosis of the breast: a rare extra-pulmonary presentation of tuberculosis.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39078781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.19024"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.",
"datePublished": "2024-06-06",
"url": "https://questionsmedicales.fr/article/38833409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.15585/mmwr.ss7304a1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Childhood tuberculosis.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QCO.0000000000000866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tuberculosis in pregnancy.",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/36002371",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bpobgyn.2022.07.006"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de type Wingless",
"item": "https://questionsmedicales.fr/mesh/D051153"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéine Wnt-5a",
"item": "https://questionsmedicales.fr/mesh/D000071818"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine Wnt-5a - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine Wnt-5a",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine Wnt-5a",
"description": "Comment diagnostiquer une anomalie de Wnt-5a ?\nQuels tests sont utilisés pour mesurer Wnt-5a ?\nWnt-5a est-il lié à des maladies spécifiques ?\nPeut-on détecter Wnt-5a dans le sang ?\nQuels biomarqueurs sont associés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine Wnt-5a",
"description": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?\nWnt-5a influence-t-il le cancer ?\nY a-t-il des signes cliniques de dysfonction de Wnt-5a ?\nWnt-5a affecte-t-il le système nerveux ?\nQuels effets sur la peau sont liés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine Wnt-5a",
"description": "Peut-on prévenir les anomalies de Wnt-5a ?\nY a-t-il des facteurs environnementaux affectant Wnt-5a ?\nComment le mode de vie influence-t-il Wnt-5a ?\nLes suppléments nutritionnels aident-ils Wnt-5a ?\nLa gestion du stress influence-t-elle Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine Wnt-5a",
"description": "Comment traiter les anomalies de Wnt-5a ?\nY a-t-il des médicaments ciblant Wnt-5a ?\nLa thérapie génique peut-elle aider Wnt-5a ?\nQuels traitements sont efficaces contre le cancer lié à Wnt-5a ?\nDes essais cliniques existent-ils pour Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine Wnt-5a",
"description": "Quelles complications sont liées à Wnt-5a ?\nWnt-5a peut-il causer des troubles métaboliques ?\nY a-t-il des risques de récidive de cancer avec Wnt-5a ?\nWnt-5a influence-t-il la réponse immunitaire ?\nDes complications neurologiques sont-elles possibles avec Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine Wnt-5a",
"description": "Quels sont les facteurs de risque pour Wnt-5a ?\nL'âge influence-t-il Wnt-5a ?\nLe tabagisme affecte-t-il Wnt-5a ?\nY a-t-il un lien entre l'alimentation et Wnt-5a ?\nLe stress chronique impacte-t-il Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Tuberculosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de Wnt-5a ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour évaluer les niveaux de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer Wnt-5a ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages ELISA et des techniques de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Wnt-5a est-il lié à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a sont associées à des cancers et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter Wnt-5a dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux de Wnt-5a peuvent être mesurés dans le sérum sanguin."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à Wnt-5a ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres protéines de la voie Wnt, comme Wnt-1 et β-caténine, peuvent être des biomarqueurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de développement, des troubles immunitaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il le cancer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est liée à la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction de Wnt-5a ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations congénitales et des troubles de la croissance peuvent être observés."
}
},
{
"@type": "Question",
"name": "Wnt-5a affecte-t-il le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a joue un rôle dans le développement neuronal et peut affecter la neurogenèse."
}
},
{
"@type": "Question",
"name": "Quels effets sur la peau sont liés à Wnt-5a ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de Wnt-5a peuvent entraîner des troubles cutanés et des cancers de la peau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de Wnt-5a ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne santé maternelle et des soins prénatals appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux affectant Wnt-5a ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des perturbateurs endocriniens peut influencer Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il Wnt-5a ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut soutenir la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels aident-ils Wnt-5a ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent moduler l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "La gestion du stress influence-t-elle Wnt-5a ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut avoir un impact positif sur la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment traiter les anomalies de Wnt-5a ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des traitements immunologiques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Wnt-5a ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des inhibiteurs de la voie Wnt sont en développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider Wnt-5a ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger les anomalies de Wnt-5a dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre le cancer lié à Wnt-5a ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements combinés de chimiothérapie et d'immunothérapie montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Des essais cliniques existent-ils pour Wnt-5a ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant la voie Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à Wnt-5a ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des malformations congénitales et des cancers avancés."
}
},
{
"@type": "Question",
"name": "Wnt-5a peut-il causer des troubles métaboliques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation de Wnt-5a peut contribuer à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive de cancer avec Wnt-5a ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est associée à un risque accru de récidive."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il la réponse immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a peut moduler la réponse immunitaire, affectant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles avec Wnt-5a ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a peuvent entraîner des complications neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour Wnt-5a ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il Wnt-5a ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il Wnt-5a ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'alimentation et Wnt-5a ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Le stress chronique impacte-t-il Wnt-5a ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies."
}
}
]
}
]
}
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.
Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile. Electronic address: ninestrosa@bio.puc.cl.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.
Tuberculosis (TB) is a major cause of ill health and one of the leading causes of death worldwide. The first step in developing strategies to reduce TB mortality is to identify the direct causes of de...
Data on patients with TB systemically collected from the National Surveillance System of South Korea from January 2019 to December 2020 were included in this study. We analyzed the clinical characteri...
Of the total of 12,340 patients with TB, 61% were males with a mean age of 61.3 years. During the follow-up period, the overall mortality rate was 10.6%, with TB-related deaths accounting for 21.3% of...
Patients with high-risk TB must be identified through cause-specific mortality analysis, and the mortality rate must be reduced through intensive monitoring of patients with a high TB burden and comor...
Breast tuberculosis (TB) is a rare extra-pulmonary presentation of tuberculosis. In the western world, this accounts for less than 0.1% of breast conditions (all breast conditions, not limited to TB o...
We report a case of a 54-year- old human immunodeficiency virus (HIV)-positive lady who presented with six months history of multiple masses on the left breast which were initially suspected to be can...
Presentation of TB can be non-specific and atypical in patients with HIV infection, especially when it presents in extra-pulmonary forms....
Elimination of tuberculosis (TB) is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. In 2022, TB incidence in the United States was 2.5 T...
The 5-year period for which the most recent data were available for each of five indicators: 1) overall TB incidence (2018-2022), 2) TB incidence among non-U.S.-born persons (2018-2022), 3) percentage...
The National TB Indicators Project (NTIP) is a web-based performance monitoring tool that uses national TB surveillance data reported through the National TB Surveillance System and the Aggregate Repo...
During the 5-year period for which the most recent data were available, most TB programs had improvements in reducing overall TB incidence (71.2%) and increasing the percentage of contacts receiving a...
This report is the first to describe a 5-year relative change for TB program performance. These results suggest that TB programs are making improvements in activities that help identify persons with T...
Use of NTIP data from individual TB programs enables a more detailed examination of trends in program performance and identification of areas for program improvement. Assessing indicator trends by TB ...
We discuss the most recent literature to support the identification of children at risk for tuberculosis and optimal testing and treatment strategies....
The identification and management of children with tuberculosis has increased in complexity due to the recent severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic, greater use of immu...
The SARS-CoV-2 pandemic will likely have a negative impact on global tuberculosis control. It is important that countries maintain a comprehensive approach to the identification and management of chil...
Due to COVID-19 pandemic, the latest progress of the End Tuberculosis (TB) Strategy was far from optimal and services for TB needs to be quickly restored. Pregnancy is a unique opportunity to screen a...
The Center for Personalized Precision Medicine of Tuberculosis (cPMTb) was constructed to develop personalized pharmacotherapeutic systems for tuberculosis (TB). This study aimed to introduce the cPMT...
Until August 2021, 964, 167, and 95 patients with TB, NTM infection, and LTBI, respectively, were included. Clinical, laboratory, and radiographic data were collected. NAT2 and SLCO1B1 phenotypes were...
Patients with TB were older, had lower body mass index (BMI), higher diabetes rate, and higher male proportion than patients with LTBI. Patients with NTM infection were older, had lower BMI, lower dia...
Understanding disease characteristics and identifying pharmacokinetic traits are fundamental steps in optimizing treatment. Further longitudinal data are required for personalized precision medicine....
This study registered ClinicalTrials.gov NO. NCT05280886....
Extrapulmonary tuberculosis (TB) presents unique diagnostic and therapeutic challenges. The site of involvement can vary widely, with common sites including the lymph nodes, pleura, skin, ear, nose an...
Tuberculosis (TB) is a significant public health problem among the Saharia community, an underprivileged tribal group in the west-central part of India. There are several challenges for India's TB con...
Despite concerted efforts, Mycobacterium tuberculosis (M.tb), the pathogen that causes tuberculosis (TB), continues to be a burden on global health, regaining its dubious distinction in 2022 as the wo...
In this review, we discuss the application of a novel replicating RNA (repRNA)-based vaccine formulated and delivered in nanostructured lipids....
Our preclinical data are the first to report that RNA platforms are a viable system for TB vaccines and should be pursued with high-priority M.tb antigens containing cluster of differentiation (CD4+) ...
This RNA vaccine shows promise for use against intracellular bacteria such as M.tb as demonstrated by the feasibility of construction, enhanced induction of cell-mediated and humoral immune responses,...
Early and rapid diagnosis of Mycobacterium tuberculosis in clinical specimen is important for the treatment of patients and control of disease transmission to the community. The disease is largely pre...